Waldencast Acquisition (WALD) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Waldencast plc reported a robust Q3 2024 performance with a 34.6% jump in comparable net revenue, driven by strong demand for its Obagi Medical and Milk Makeup brands. The company’s adjusted EBITDA surged by 134% compared to the previous year, reflecting strategic brand enhancements and operational efficiencies. Despite facing significant non-recurring costs, Waldencast maintained healthy cash conversion, supported by effective capital management.
For further insights into WALD stock, check out TipRanks’ Stock Analysis page.
